My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format

Send to:

Choose Destination

    Psychopharmacol Bull. 1991;27(4):637-43.

    Should bupropion dosage be adjusted based upon therapeutic drug monitoring?

    Preskorn SH.

    Psychiatric Research Institute, St. Francis Regional Medical Center, Wichita, KS 67214.

    Bupropion is the next antidepressant which should be studied aggressively to test the value of therapeutic drug monitoring (TDM). This paper will present the basis for this conclusion.

    PMID: 1813908 [PubMed - indexed for MEDLINE]

    Publication Types, MeSH Terms, Substances

    Publication Types:

    MeSH Terms:

    Substances:

    LinkOut - more resources

    Molecular Biology Databases:

    Libraries:

    Supplemental Content

    Related articles

    Cited by 1 PubMed Central article

    All links from this record

    • Related Articles

      Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.

    • Compound (MeSH Keyword)

      PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

    • Substance (MeSH Keyword)

      PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

    • Cited in PMC

      Full-text articles in the PubMed Central Database that cite the current articles.

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk